Details for 2015155712

Up to date per 28.05.2026

Actions

Title / Product Name

Antikörper-Formulierungen

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2015155712

EP Publication Number

2889310

E-Number

956284

Language

PCT Number

Publication Date

01.07.2015 A

20.12.2017 B1

Registration Date

20.12.2017

AT Publication Date

15.01.2018

Application Date

03.07.2008

Registration Number

Priorities

06.07.2007

948220 P

IPC

C07K 16/00 20060101AFI20150415BHEP

Maximum Duration of Protection

03.07.2028

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

Brisbane, Charlene EGlaxoSmithKline 709 Swedeland Road King of Prussia, PA 19406US

Ketkar, Amol SharadGlaxoSmithKline 709 Swedeland Road King of Prussia, PA 19406US

Lashmar, Ulla Tovec/o GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford Middlesex TW8 9GSGB

Information about Fees